Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
61
-
80
of
214
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
61
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
62
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
63
CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
64
CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
65
CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia
Published 2020
CADTH
Read Now
66
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
Read Now
67
CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)
Published 2020
CADTH
Read Now
68
CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine
Published 2019
CADTH
Read Now
69
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
Read Now
70
CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients 1 yea...
Published 2019
CADTH
Read Now
71
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
72
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
73
Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
74
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
75
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
76
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
77
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic -- Ipsen Biopharmaceuticals Canada Inc.) : indication: for the symptomatic treatment of...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
78
CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
79
CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
80
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
201
330 - Economics
113
140 - Specific philosophical schools
24
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
800 - Literature & rhetoric
2
more ...
380 - Commerce, communications & transportation
1
see all ...
less ...
Language
English
214
Collection
National Center for Biotechnology Information
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
161
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=4&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&type=AllFields
Send by Email
×
Loading...